"But things didn't shake out that way. A military regulatory expert contacted the FDA with concerns about Theranos' technology without telling the company first, stalling the project and prompting Holmes to reach out to Mattis for help.
"I would very much appreciate your help in getting this information corrected with the regulatory agencies," Holmes wrote in an email to Mattis, saying that since the "misinformation came from within DOD, it would be "invaluable" to have the information "formally corrected by the right people in the DOD."
"But things didn't shake out that way. A military regulatory expert contacted the FDA with concerns about Theranos' technology without telling the company first, stalling the project and prompting Holmes to reach out to Mattis for help.
"I would very much appreciate your help in getting this information corrected with the regulatory agencies," Holmes wrote in an email to Mattis, saying that since the "misinformation came from within DOD, it would be "invaluable" to have the information "formally corrected by the right people in the DOD."